Final APPLY-PNH Data Support Use of Iptacopan in PNH With Pe

Oral iptacopan (Fabhalta) monotherapy induced durable responses and hemolysis control in patients with paroxysmal nocturnal hemoglobinuria and persistent anemia who had previously received anti-C5 treatment.

Related Keywords

, Antoniom Risitano , Bone Marrow Transplantation Program , University Of Naples Federico , Naples Federico , Oral Iptacopan Monotherapy , Patients With Paroxysmal Nocturnal Hemoglobinuria And Persistent Anemia , Apply Pnh Trial , Nct04558918 , D , Phd , University Of Naples Federico Ii ,